Biotech Valuation Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Valuation

CRSP 52.51

+2.7%

Nov 14 3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Biomaven who started this subject	9/1/2000 12:06:59 AM
From: tommysdad	Read Replies (2) of 52153

Since the point of this thread is Biotech Valuation, let's take a poll: How many people think the discovery of ACE2 is worth a billion in market cap to Millenium? Keeping in mind that: a) they don't own it outright (collaboration with Lilly) b) it's not a validated target for therapeutic intervention (yet -- though odds are it's going to be) c) known ACE inhibitors do not inhibit the enzyme, so designing a good inhibitor may (or may not) be difficult If MLNM had said: "we found ACE2, here's what it does, and we have some advanced lead molecules", I might expect a nice pop. But an additional BILLION in market cap? That's 2-3 reasonable sized biotechs with their own proprietary targets. (um, my vote is: not worth that kind of pop)

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next